Log in to save to my catalogue

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8690919

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

About this item

Full title

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

Publisher

Australia: Ivyspring International Publisher Pty Ltd

Journal title

Theranostics, 2022, Vol.12 (1), p.1-17

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher Pty Ltd

More information

Scope and Contents

Contents

Administration of potent anti-receptor-binding domain (RBD) monoclonal antibodies has been shown to curtail viral shedding and reduce hospitalization in patients with SARS-CoV-2 infection. However, the structure-function analysis of potent human anti-RBD monoclonal antibodies and its links to the formulation of antibody cocktails remains largely el...

Alternative Titles

Full title

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8690919

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8690919

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.65563

How to access this item